SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

This study has been completed.

Study NCT00005822 Information provided by Case Comprehensive Cancer Center

First Received: June 2, 2000 Last Updated: June 10, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2003
Primary Completion Date:	December 2002 (Final data collection date for primary outcome measure)